Know Cancer

or
forgot password

    • cancer clinical trials in normal, IL

    • Pemetrexed, Carboplatin, and Bevacizumab as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Community Cancer Center

    Trial Locations
    Community Cancer Center
    Illinois CancerCare - Community Cancer Center
    Lung Cancer
    Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center
    Illinois CancerCare - Community Cancer Center
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer
    Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
    Illinois CancerCare - Community Cancer Center
    Normal, Illinois 61761
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer
    Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center Foundation
    Illinois CancerCare-Community Cancer Center
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Carboplatin and Paclitaxel Combined With Cetuximab and/or Cixutumumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Illinois CancerCare-Community Cancer Center
    Normal, Illinois 61761
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
    Mid-Illinois Hematology-Oncology Associates at Community Cancer Center
    Normal, Illinois 61761
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Bortezomib, Liposomal Doxorubicin Hydrochloride, Dexamethasone, and Cyclophosphamide in Treating Patients With Multiple Myeloma That Relapsed After Autologous Stem Cell Transplant
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center Foundation
    Refractory Multiple Myeloma
    Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis
    Illinois CancerCare-Community Cancer Center
    Normal, Illinois 61761
    Light Chain Deposition Disease, Primary Systemic Amyloidosis
    Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
    Illinois CancerCare - Community Cancer Center
    Normal, Illinois 61761
    Breast Cancer
    Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center
    Colorectal Cancer, Metastatic Cancer
    Vitamin D and Breast Cancer Biomarkers in Female Patients
    Illinois CancerCare - Community Cancer Center
    Normal, Illinois 61761
    Breast Cancer
    Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center Foundation
    Illinois CancerCare-Community Cancer Center
    Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia